BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2013
View Archived Issues
Oncothyreon presents results from two phase II studies of PX-866
Read More
Researchers describe unique properties of diabetes treatment candidate SKL-18287
Read More
Crolibulin combined with cisplatin shows activity in anaplastic thyroid cancer
Read More
Recommended phase II dose of MLN-2480 determined in patients with solid tumors
Read More
Merck Serono reports results of APRIL-SLE study of atacicept
Read More
Macquarie University awarded grant to support development of cancer diagnostics
Read More
Astex Pharmaceuticals to submit IND for ASTX-727
Read More
Cellectis achieves proof of concept in in vivo testing of curative therapy for leukemia
Read More
Serodus ASA to merge with Phlogo ApS
Read More
Loxo Oncology and Array BioPharma enter license and collaboration agreement
Read More
Emergent BioSolutions completes phase III trial of BioThrax
Read More
Roche presents novel RORgamma modulators for arthritis
Read More
Cellzome patents new tyrosine-protein kinase inhibitors
Read More
FDA to review application seeking new indication for Eliquis
Read More
Phase III study of Revlimid in newly diagnosed multiple myeloma meets primary endpoint
Read More
CRUISE-1 phase III trial of iron-delivery drug SFP meets primary endpoint
Read More
BARDA releases additional funding to support BioCryst filing of peramivir NDA
Read More
pSivida discloses interim data from investigator-sponsored study of micro-insert in uveitis
Read More
Boehringer Ingelheim divulges novel reverse transcriptase inhibitors
Read More
ProMetic set to advance lead antifibrotic drug candidate PBI-4050 to clinic
Read More
Scientists at Roche synthesize new PAK 1 inhibitors
Read More
Merck KGaA designs novel PAMs of muscarinic M1 receptor
Read More
Ultragenyx obtains worldwide license for triheptanoin
Read More
Biodel completes dosing in phase II trial of ultra-rapid-acting injectable mealtime insulin BIOD-123
Read More
Mitsubishi Tanabe Pharma to acquire Medicago
Read More